Design and use of silica-containing redox nanoparticles, siRNPs, for high-performance peritoneal dialysis

Biomaterials Science

Volumn 2, Issue 4, 2014, Pages 522-529

  Nagasaki, Yukio ^a   Yaguchi, Tatsuya ^a   Matsumura, Takuma ^a   Yoshitomi, Toru ^a   Ikeda, Yutaka ^a   Ueda, Atsushi ^b   Hirayama, Aki ^c  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b UNIVERSITY OF TSUKUBA HOSPITAL   (Japan)

^c TSUKUBA UNIVERSITY OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; NANOPARTICLES; SILICA;

ADSORPTION CAPACITIES; BLOOD UREA NITROGENS; EFFECTIVE CONCENTRATION; INTRAPERITONEAL INJECTIONS; LOW-MOLECULAR WEIGHT; PERITONEAL DIALYSIS; PROTECTIVE EFFECTS; SCAVENGE REACTIVE OXYGEN SPECIES;

DIALYSIS;

CHLORHEXIDINE GLUCONATE; CREATININE; NANOPARTICLE; NITROXIDE; SILICON DIOXIDE; TEMPOL; UREA;

ADSORPTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIALYSATE; IN VITRO STUDY; IN VIVO STUDY; MALE; MATERIALS TESTING; NONHUMAN; OXIDATIVE STRESS; PERITONEAL CAVITY; PERITONEAL DIALYSIS; PERITONEAL FIBROSIS; PRIORITY JOURNAL; QUALITY OF LIFE; RAT; UREA NITROGEN BLOOD LEVEL;

EID: 84895827607     PISSN: 20474830     EISSN: 20474849     Source Type: Journal    
DOI: 10.1039/c3bm60236b     Document Type: Article

References (25)

1. A. Grassmann S. Gioberge S. Moeller G. Brown ESRD patients in 2004: global overview of patient numbers, treatment modalities and associated trends Nephrol. Dial. Transplant. 2005 27 2587 2593
2. F. Locatelli A. Cavalli B. Tucci The growing problem of intradialytic hypertension Nat. Rev. Nephrol. 2010 6 41 48
3. M. K. Shamseddin P. S. Parfrey Sudden cardiac death in chronic kidney disease: epidemiology and prevention Nat. Rev. Nephrol 2011 7 145 154
4. K. Sennfält M. Magnusson P. Carlsson Comparison of hemodialysis and peritoneal dialysis-a cost-utility analysis Perit. Dial. Int. 2002 22 39 47
5. S. P. MacDonald M. R. Marshall D. W. Johnson K. R. Polkinghorne Relationship between Dialysis Modality and Mortality J. Am. Soc. Nephrol. 2009 20 155 163
6. T. C. Lin M. T. Kao M. N. Lai C. C. Huang Mortality difference by dialysis modality among new ESRD patients with and without diabetes mellitus Dial. Trasplant. 2006 35 234
7. D. W. Johnson Y. Cho B. E. R. Livingston C. M. Hawley S. P. McDonald F. G. Brown et al., Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes Kidney Int. 2010 77 904 912
8. H. Kawanishi Encapsulating peritoneal sclerosis Nephrology 2005 10 249 255
9. M. C. Brown K. Simpson J. J. Kerssens R. A. Mactier Encapsulating Peritoneal Sclerosis in the New Millennium, A National Cohort Study Clin. J. Am. Soc. Nephrol. 2009 4 1222 1229
10. M. A. Glomb V. M. Monnier Mechanism of Protein Modification by Glyoxal and Glycolaldehyde, Reactive Intermediates of the Maillard Reaction J. Biol. Chem. 1995 270 10017 10026
11. G. Abraham E. Savin A. Ayiomamitis S. Izatt S. I. Vas R. E. Mathews et al., Natural history of exit-site infection (ESI) in patients on continuous ambulatory peritoneal dialysis (CAPD) Perit. Dial. Int. 1988 8 211 216
12. Y. Nagasaki Nitroxide radicals and nanoparticles: a partnership for nanomedicine radical delivery Therapeut. Deliv. 2012 3 165 179
13. T. Yoshitomi R. Suzuki T. Mamiya H. Matsui A. Hirayama Y. Nagasaki pH-Sensitive Radical-Containing-Nanoparticle (RNP) for the L-Band-EPR Imaging of Low pH Circumstances Bioconjugate Chem. 2009 20 1792 1798
14. M. Shimizu T. Yoshitomi Y. Nagasaki J. Clin. Biochem. Nutr.
15. A. Marushima K. Suzuki Y. Nagasaki T. Yoshitomi K. Toh H. Tsurushima et al., Newly Synthesized Radical-containing Nanoparticles (RNP) Enhance Neuroprotection after Cerebral Ischemia-reperfusion Injury Neurosurgery 2011 68 1418 1426
16. T. Yoshitomi A. Hirayama Y. Nagasaki The ROS scavenging and renal protective effects of pH-responsive nitroxide radical-containing nanoparticles Biomaterials 2011 32 8021 8028
17. P. Chonpathompikunlert C. H. Fan Y. Ozaki T. Yoshitomi C. K. Yeh Y. Nagasaki Redox nanoparticle treatment protects against neurological deficit in focused ultrasound-induced intracerebral hemorrhage Nanomedicine 2012 7 1029 1043
18. T. Yoshitomi Y. Ozaki S. Thangavel Y. Nagasaki Redox nanoparticle therapeutics to cancer - increase in therapeutic effect of doxorubicin, suppressing its adverse effect J. Controlled Release 2013 172 137 143
19. L. B. Vong T. Tomita T. Yoshitomi H. Matsui Y. Nagasaki An Orally Administered Redox Nanoparticle That Accumulates in the Colonic Mucosa and Reduces Colitis in Mice Gastroenterology 2012 143 1027 1036
20. S. Sha L. B. Vong P. Chonpathompikunlert T. Yoshitomi H. Matsui Y. Nagasaki Suppression of NSAID-induced small intestinal inflammation by orally administered redox nanoparticles Biomaterials 2013 34 8393 8400
21. T. Yoshitomi D. Miyamoto Y. Nagasaki Design of Core-Shell-Type Nanoparticles Carrying Stable Radicals in the Core Biomacromolecules 2009 10 596 601
22. D. Bozkurt E. Hur B. Ulkuden M. Sezak H. Nar O. Purclutepe et al., Can N-acetylcysteine preserve peritoneal function and morphology in encapsulating peritoneal sclerosis Perit. Dial. Int. 2009 29 S202 S205
23. C. M. Hoff Experimental animal models of encapsulating peritoneal sclerosis Perit. Dial. Int. 2005 25 S57 S66
24. B. Rippe D. Venturoli O. Simonsen J. de Arteaga Fluid and electrolyte transport across the peritoneal membrane during CAPD according to the three-pore model Perit. Dial. Int. 2004 24 10 27
25. H. Terawaki Y. Hayashi W. J. Zhu Y. Matsuyama T. Terada S. Kabayama et al., Transperitoneal administration of dissolved hydrogen for peritoneal dialysis patients: a novel approach to suppress oxidative stress in the peritoneal cavity Med. Gas. Res. 2013 3 14